Etanercept biosimilar (Mochida)

依那西普生物类似药 (Mochida)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEtanercept biosimilar (Mochida)
Drug Alias Name依那西普生物仿制药 (Mochida)TNFceptLBEC-0101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionTumor necrosis factor β inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor βTumor necrosis factor α
Therapy Area/IndicationsArthritis, RheumatoidArthritis, Juvenile
Global Approved IndicationsArthritis, RheumatoidArthritis, Juvenile
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2018/01/19
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical LtdMochda Pharmaceutical Co Ltd
Active IndicationsArthritis, RheumatoidArthritis, Juvenile
Inactive IndicationsN/A

Other Information

ATC CodeL04AB01
Related LinksN/A